Gene · 5350
Papers4,369
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,369
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions. | Front Pharmacol | 2021 | 34987383 | PubTator, text mining | PubMed |
| Phenotypic Variability in iPSC-Induced Cardiomyocytes and Cardiac Fibroblasts Carrying Diverse LMNA Mutations. | Front Physiol | 2021 | 34975533 | PubTator, text mining | PubMed |
| Clinical and genetic features of arrhythmogenic cardiomyopathy: diagnosis, management and the heart failure perspective. | Prog Pediatr Cardiol | 2021 | 34970070 | PubTator, text mining | PubMed |
| Nutritional Behaviors, Health Literacy, and Health Locus of Control of Secondary Schoolers in Southern Poland: A Cross-Sectional Study. | Nutrients | 2021 | 34959875 | PubTator, text mining | PubMed |
| Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy. | Front Cardiovasc Med | 2021 | 34950711 | PubTator, text mining | PubMed |
| Characterization of the PLN p.Arg14del Mutation in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. | Int J Mol Sci | 2021 | 34948294 | PubTator, text mining | PubMed |
| Familial Dilated Cardiomyopathy and Sudden Cardiac Arrest: New Association with a SCN5A Mutation. | Genes (Basel) | 2021 | 34946838 | PubTator, text mining | PubMed |
| The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases. | J Pers Med | 2021 | 34945845 | PubTator, text mining | PubMed |
| Catestatin as a Biomarker of Cardiovascular Diseases: A Clinical Perspective. | Biomedicines | 2021 | 34944578 | PubTator, text mining | PubMed |
| Development of a 3-Dimensional Model to Study Right Heart Dysfunction in Pulmonary Arterial Hypertension: First Observations. | Cells | 2021 | 34944102 | PubTator, text mining | PubMed |
| Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform-A Cardiac Perspective. | Cells | 2021 | 34943991 | PubTator, text mining | PubMed |
| When Should Premature Ventricular Contractions Be Considered as a Red Flag in Children with Cardiomyopathy? | J Cardiovasc Dev Dis | 2021 | 34940531 | PubTator, text mining | PubMed |
| Artificial Intelligence-Driven Algorithm for Drug Effect Prediction on Atrial Fibrillation: An in silico Population of Models Approach. | Front Physiol | 2021 | 34938202 | PubTator, text mining | PubMed |
| Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model. | JCO Clin Cancer Inform | 2021 | 34936469 | PubTator, text mining | PubMed |
| Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity. | Front Pediatr | 2021 | 34926342 | PubTator, text mining | PubMed |
| Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study. | Front Oncol | 2021 | 34926257 | PubTator, text mining | PubMed |
| Association Study of Genetic Variants in Calcium Signaling-Related Genes With Cardiovascular Diseases. | Front Cell Dev Biol | 2021 | 34912794 | PubTator, text mining | PubMed |
| Biomarkers in the clinical management of patients with atrial fibrillation and heart failure. | J Geriatr Cardiol | 2021 | 34908928 | PubTator, text mining | PubMed |
| Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy. | Nat Commun | 2021 | 34887420 | PubTator, text mining | PubMed |
| Recent and Upcoming Drug Therapies for Pediatric Heart Failure. | Front Pediatr | 2021 | 34858897 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5350/papers?page=54